Arcutis Biotherapeutics, Inc., a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, reported financial results for the quarter ended March 31, 2020 and provided a business update.
May 12, 2020
· 9 min read